Clinical Trial Update: Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care [NA]

View source ↗

Summary

A terminated clinical trial comparing the OraQuick HCV Rapid Antibody Test with standard serologic screening to assess validity, acceptability, and impact on li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• OraQuick HCV Rapid Antibody Test

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Active or Ex-injection Drug Users, Indication of Hepatitis C Screening | NA | Status: TERMINATED